
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 March 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 3MB, 220 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“Accelerated FEV(1) decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients”, Eur Respir J, 2020.
, “Acute kidney injury in stable COPD and at exacerbation”, Int J Chron Obstruct Pulmon Dis, vol. 10, pp. 2067-77, 2015.
, “Asthma-Related Health Outcomes Associated with Short-Acting β(2)-Agonist Inhaler Use: An Observational UK Study as Part of the SABINA Global Program”, Adv Ther, 2020.
, “Bronchiectasis and the risk of cardiovascular disease: a population-based study”, Thorax, vol. 72, pp. 161-166, 2017.
, “Cardiovascular disease in patients with primary and secondary adrenal insufficiency and the role of comorbidities”, J Clin Endocrinol Metab, 2021.
, “Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study”, Eur Respir J, vol. 47, pp. 186-93, 2016.
, “Changing causes of death for patients with chronic respiratory disease in England, 2005-2015”, Thorax, 2019.
, “Characteristics Associated with Accelerated Lung Function Decline in a Primary Care Population with Chronic Obstructive Pulmonary Disease”, Int J Chron Obstruct Pulmon Dis, vol. 15, pp. 3079-3091, 2020.
, “Chronic obstructive pulmonary disease and the risk of 12 cardiovascular diseases: a population-based study using UK primary care data”, Thorax, vol. 73, pp. 877-879, 2018.
, “Clinical profile of predefined asthma phenotypes in a large cohort of UK primary care patients (Clinical Practice Research Datalink)”, J Asthma Allergy, vol. 12, pp. 7-19, 2019.
, “Closing the mortality gap after a myocardial infarction in people with and without chronic obstructive pulmonary disease”, Heart, vol. 101, pp. 1103-10, 2015.
, “Completeness and validity of alcohol recording in general practice within the UK: a cross-sectional study”, BMJ Open, vol. 9, p. e031537, 2019.
, “Concomitant diagnosis of asthma and COPD: a quantitative study in UK primary care”, Br J Gen Pract, vol. 68, pp. e775-e782, 2018.
, “COPD disease severity and the risk of venous thromboembolic events: a matched case-control study”, Int J Chron Obstruct Pulmon Dis, vol. 11, pp. 899-908, 2016.
, , “Development and Validation of a Method to Estimate COPD Severity in Multiple Datasets: A Retrospective Study”, Pulm Ther, 2020.
, “Effect of beta blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare records”, Bmj, vol. 347, p. f6650, 2013.
, “Effects of Pulmonary Rehabilitation on Exacerbation Number and Severity in People With COPD: An Historical Cohort Study Using Electronic Health Records”, Chest, vol. 152, pp. 1188-1202, 2017.
, , “Exacerbation risk and characterisation of the UK's asthma population from infants to old age”, Thorax, vol. 73, pp. 313-320, 2018.
, “External validation of ADO, DOSE, COTE and CODEX at predicting death in primary care patients with COPD using standard and machine learning approaches”, Respir Med, vol. 138, pp. 150-155, 2018.
, “Feasibility of using Clinical Practice Research Datalink data to identify patients with chronic obstructive pulmonary disease to enrol into real-world trials”, Pharmacoepidemiol Drug Saf, 2020.
, “Identifying clinically important COPD sub-types using data-driven approaches in primary care population based electronic health records”, BMC Med Inform Decis Mak, vol. 19, p. 86, 2019.
, “Improved incidence estimates from linked vs. stand-alone electronic health records”, J Clin Epidemiol, vol. 75, pp. 66-9, 2016.
, “Inadequate specialist care referrals for high-risk asthma patients in the UK: an adult population-based cohort 2006-2017”, J Asthma, pp. 1-7, 2019.
, “Incidence of community-acquired lower respiratory tract infections and pneumonia among older adults in the United Kingdom: a population-based study”, PLoS One, vol. 8, p. e75131, 2013.
, “Incidence of type II diabetes in chronic obstructive pulmonary disease: a nested case-control study”, NPJ Prim Care Respir Med, vol. 29, p. 28, 2019.
, “Increased mortality risk in patients with primary and secondary adrenal insufficiency”, J Clin Endocrinol Metab, 2021.
, “Indirect acute effects of the COVID-19 pandemic on physical and mental health in the UK: a population-based study”, Lancet Digit Health, 2021.
, “Inhaled corticosteroids, blood eosinophils, and FEV1 decline in patients with COPD in a large UK primary health care setting”, Int J Chron Obstruct Pulmon Dis, vol. 14, pp. 1063-1073, 2019.
, “Myocardial Infarction and Ischemic Stroke after Exacerbations of Chronic Obstructive Pulmonary Disease”, Ann Am Thorac Soc, vol. 15, pp. 935-946, 2018.
, “Natural History of Chronic Obstructive Pulmonary Disease Exacerbations in a General Practice-based Population with Chronic Obstructive Pulmonary Disease”, Am J Respir Crit Care Med, vol. 198, pp. 464-471, 2018.
, “No association between exacerbation frequency and stroke in patients with COPD”, Int J Chron Obstruct Pulmon Dis, vol. 11, pp. 217-25, 2016.
, “Nontuberculous mycobacterial disease managed within UK primary care, 2006-2016”, Eur J Clin Microbiol Infect Dis, vol. 37, pp. 1795-1803, 2018.
, “Predicting COPD 1-year mortality using prognostic predictors routinely measured in primary care”, BMC Med, vol. 17, p. 73, 2019.
, “Prediction of five-year mortality after COPD diagnosis using primary care records”, PLoS One, vol. 15, p. e0236011, 2020.
, “Real world effects of COPD medications: a cohort study with validation against RCT results”, Eur Respir J, 2020.
, “Real-world effects of medications for chronic obstructive pulmonary disease: protocol for a UK population-based non-interventional cohort study with validation against randomised trial results”, BMJ Open, vol. 8, p. e019475, 2018.
, “Recording of hospitalizations for acute exacerbations of COPD in UK electronic health care records”, Clin Epidemiol, vol. 8, pp. 771-782, 2016.
, “Recruitment of patients with Chronic Obstructive Pulmonary Disease (COPD) from the Clinical Practice Research Datalink (CPRD) for research”, NPJ Prim Care Respir Med, vol. 28, p. 21, 2018.
, “Risk factors and secondary care utilisation in a primary care population with non-tuberculous mycobacterial disease in the UK”, Eur J Clin Microbiol Infect Dis, 2018.
, “Risk factors for hospital admission in the 28 days following a community-acquired pneumonia diagnosis in older adults, and their contribution to increasing hospitalisation rates over time: a cohort study”, BMJ Open, vol. 5, p. e008737, 2015.
, “Temporal Trends in the Incidence of Heart Failure among Patients with COPD and Its Association with Mortality”, Ann Am Thorac Soc, 2020.
, “Validation of asthma recording in the Clinical Practice Research Datalink (CPRD)”, BMJ Open, vol. 7, p. e017474, 2017.
, “Validation of chronic obstructive pulmonary disease recording in the Clinical Practice Research Datalink (CPRD-GOLD)”, BMJ Open, vol. 4, p. e005540, 2014.
, “Validation of the Recording of Acute Exacerbations of COPD in UK Primary Care Electronic Healthcare Records”, PLoS One, vol. 11, p. e0151357, 2016.
, “Validity and interpretation of spirometric recordings to diagnose COPD in UK primary care”, Int J Chron Obstruct Pulmon Dis, vol. 12, pp. 1663-1668, 2017.
,